Letter to the Editor re: the Letter to the Editor by Dr. David Samuel Henry Bell, MD regarding “The risk of developing coronary artery disease or congestive heart failure, and overall mortality, in type 2 diabetic patients receiving rosiglitazone, pioglitazone, metformin, or sulfonylureas: a retrospective analysis”

✍ Scribed by Robert S. Zimmerman; Kevin Matthew Pantalone

• Publisher: Springer
• Year: 2009
• Tongue: English
• Weight: 82 KB
• Volume: 46
• Category: Article
• ISSN: 0940-5429
• DOI: 10.1007/s00592-009-0111-x